Pitch Introduction
The Renal Project dialysis centers are re-imagining kidney care in India. Featured on Shark Tank India Season 1, the start-up promises accessible, affordable dialysis to rural and urban patients alike—eliminating the need to travel hundreds of kilometers for life-sustaining treatment.
Business Overview
Product/Service: The Renal Project operates compact dialysis facilities inside small towns and delivers home dialysis kits with trained technicians. Problem It Solves: 1.5 crore Indians live with kidney disease; only 2,500 dialysis-capacity hospitals exist, mostly in metro cities. Target Market: Tier-2/3 towns, semi-urban districts, and chronic kidney patients seeking home care. Unique Selling Proposition: Tech-powered scheduling, paperless flow sheets, hygienic clinics inside taluka towns plus trained nurses doing evening home visits.
| Key Metrics | Jan-22 Status |
|---|---|
| Centers Open | 20 completed, 21st inauguration |
| Monthly Revenue | ₹25,00,000 |
| 3-Year Open Plan | 1000+ outlets |
| Founder’s Background | Masters in Bio-med Eng. (UT Austin) |
| Pateints Treated to date | 1000+ kidney patients dialyzed |
About Founder’s
Shashank Modhia, a US-trained bio-medical engineer, worked for a European dialysis-manufacturing company in the Asia-Pacific region until 2019. Watching manufacturers focus only on big-hospital machines, he quit to solve the “vacuum of last-mile kidney care” in India. His co-founder Jitesh Pednekar is an on-ground operations expert driving day-to-day clinic roll-outs.
- 10 yrs experience configuring dialysis tech in 12 countries
- Convinced hospital-phobic taluka patients to accept home dialysis
- Developed in-house clinic management software to log every vitals
- Boot-strapped first 9 centers before Shark Tank appearance
Shark’s and Founder’s QnA
Namita: What is unique about your proposition; isn’t dialysis already available?
Shashank: Setting up the machine is easy, managing a compliant center every day in small towns is the real barrier. Surprisingly, half-capacity hospitals don’t want the “hassle”, leaving a gap for us.
Namita: How many kidney patients exist?
Shashank: India currently has 10–15 lakh diagnosed patients on dialysis. An additional 2.5 lakh join that pool every year.
Aman: Break-down of sales channels?
Shashank: 45% home dialysis, 40% satellite clinics, 15% insurance-run panels.
Vineeta: CAPEX for each center?
Shashank: A 6-bedded center is set up at Rs 18–20 lakh including generator and RO water plant.
Anupam: Are you actually profitable at unit level?
Shashank: Yes, all operating centers turned EBTIDA-positive by month-4; we track bed-utilisation real time on our dashboards.
Namita: What will you do with 1 crore Rupees?
Shashank: ₹75 lakh of the round will be capex into two new centers, ₹25 lakh for head-hire nurses and field techs to maintain quality as we replicate.
Key Stats & Financials
Before Shark Tank, The Renal Project recorded a 3 Cr ARR, pushing 1,000-plus successful dialysis cycles a month across Mumbai-Pune-Nashik belt.
- Sales: ₹25 lakh monthly run-rate within 20 months since start
- Margins: Center-level EBITDA 20% at 65% occupancy; gross margin 40%
- Valuation: Founder valued company at ₹33.3 cr (Aspiration) vs ₹16.7 cr (Deal closed)
- Investment Request: ₹1 cr for 3%
- Use of Funds: Rapid roll-out of centres, tech upgrading and hiring specialist nurses
| Money-Ask | Final Deal Compared |
|---|---|
| ₹1 Cr for 3% | ₹50L equity, ₹50L optional loan |
| Equity offered upfront | Raised to 6% after discussion |
| Bed utilization tracked | Dashboard shows 70% at mature centers |
| Debt taken from Aman | 0% |
Business Potential and TAM
Kidney failure incidence in India is rising 15% YoY, yet 60% districts still lack functional dialysis centers. Policy push via PM-DAY & state insurance is subsidising every session. Early mover expanding in these geography pockets owned district hospitals will enjoy deep moat, logistical barriers make large chain entry slow.
- Total addressable dialysis market: ~$3 B by 2027
- Serviceable Indian market: 4,000 town clusters needing 400-800 centers each
- Insurance partnerships with Arogya-De-Councils cover ₹1,000 per session
- Franchise-possible model to penetrate North & East sooner than competitor chains
The Renal Project dialysis centers: Ideal Target Audience & Demographics
| Demographic | Details |
|---|---|
| Age | 35–75, chronic kidney disease stage-4 & 5 |
| Location | Tier-2/3 towns within 5-km radius of our clinic |
| Income | ₹8k–30k per month; insured via Ayushman-Golden cards |
| Care-seekers | Patient + spouse/son looking for hygiene & proximity |
Marketing and Distribution Strategy
The Renal Project markets free kidney-screening camps with local labs to harvest need. Google Business Listing, regional-language patient education help them claim organic-distance-search queries. They empower doctors with revenue-share for referring stable cases, maintaining strict SOPs to avoid over-treatment. Future Roadmap includes franchising brand, plus launching tele-nephrology second-opinion app to increase ACV.
- Partnership with 80 local labs, 20 private hospitals for cross referral
- Instagram reels featuring patient stories, reaching 1.2 M views
- Rural radio ads on local FM channels—low cost, daily play
- FY-25 target: White-label franchise pack to open two centers each district
The Renal Project Deal Outcome
After negotiations, Namita Thapar and Aman Gupta agreed to jointly put ₹50 lakh each for 6% total equity, cutting founder’s ask valuation by half to ₹16.67 cr. No royalty or debt element existed in final term-sheet.
| Investors in Deal | Amount/equity |
|---|---|
| Namita Thapar | ₹50 L for 3% |
| Aman Gupta (boAt) | ₹50 L for 3% |
| Valuation closed | ₹16.67 Cr |
| Cash+Support | Access to pharmacy & insurance links |
The Renal Project Post-Show Update
Latest LinkedIn update shows expansion to 32 active centers, tie-up with Varun Beverages’ CSR wing to sponsor free dialysis in Haryana. Company now offers DM-accredited infection-control certification training to help partners replicate faster.
Business Analysis & Lessons
In India’s tier-3 healthcare play, perception becomes reality: Doctors, patients and investors assume “standard exists only in metros”. The Renal Project proved otherwise by focusing on disciplined execution—stock control, nurse training and unit-level profit. The founders balanced ambition with numbers, humbly accepting valuation re-score that doubled investors’ safety but still secured capital they needed to expand.
- Nail unit-economics early to attract sharks with operational confidence
- Bring deep domain knowledge (Shashank) alongside sales/ops partner co-founder
- Offer hybrid offering (clinic + home) to widen ARPU without extra location
- Negotiate smart—accept dilution when data supports realistic growth